Deloitte

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
13.09.2023 • TopicsStrategy

European Chemicals Pulse Check

In its latest European Chemicals Pulse Check, Deloitte surveyed senior executives in the European chemical industry and industry associations about their views on current market challenges, trends and opportunities.

Photo
18.10.2022 • TopicsTechnology

AI Maturity Model for GxP Application

Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP-regulated areas also want to use AI in a beneficial way, but only a small fraction of companies follows a systematic approach for the digitalization of their operations and validation. However, the assurance of integrity and quality of outputs via computerized system validation is essential for applications in GxP environments.

Photo
13.08.2019 • News

Ineos Replaces PwC with Deloitte

Olefins and polyolefins giant Ineos is switching auditors after a breakdown in communication between long-term partner PriceWaterhouseCoopers (PwC), which has audited the chemical group since its 1998 creation, and Ineos chairman and controlling 60% shareholder Jim Ratcliffe.

Photo
10.05.2019 • TopicsChemistry

Chemical Distribution 4.0

“68% of chemicals worth $76 billion will be sold online within the next five years.” This was the message from leading market research institutes and consultants in 2000, at the start of the new millennium.

Photo
26.04.2018 • TopicsChemistry

Who is the Future “Chemazon”?

The traditional business model of chemical distributors is currently fundamentally challenged on one side by digitally enabled activities from principals, logistics providers, customers, start-ups, larger chemical distributors or combinations of smaller players, who try their own online channels, and on the other side by general e-retailers like Alibaba or Amazon, who explore to enter also into chemical & material categories.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.